Evaluate Effect of Optison on Pulmonary Artery Systolic Pressure (PASP) and Pulmonary Vascular Resistance (PVR).
Clinical trial NCT00878878 · COMPLETED
Trial details
- NCT number
- NCT00878878
- Sponsor
- GE Healthcare
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2010-07-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.